JTI Reports 10.7% Net Income Growth in Q2 2022

Jul.30.2022
JTI Reports 10.7% Net Income Growth in Q2 2022
JTI Group reports a strong performance with net income of 1.27 trillion yen ($95 billion) in Q2 2022.

The JTI Group has reported a net income of JPY 1.27 trillion (USD 9.5 billion) for the second quarter of 2022, reflecting a year-on-year growth of 10.7% compared to 2021. When calculated at a fixed exchange rate, the income growth reached 3.7%, which totaled JPY 1.14 trillion. The adjusted operating profit increased by 8% at a fixed currency rate, reaching JPY 338.77 billion. The profit also increased by 17.3% to JPY 264.1 billion.


There is no context or information provided to translate into standard journalistic English. Please provide more details or a sentence for context.


Masamichi Terabatake, President and CEO of JTI Group, announced that the company's performance in the first half of the year was strong, largely driven by advantageous product pricing. He also expressed encouragement with the performance of Ploom X and stated that the company will take advantage of Japan's expertise to guide the international release of the product in the second half of this year.


As a result of favorable fluctuations in the Chinese yuan against the Japanese yen, we have revised upwards our adjusted operating profit and profit forecasts for full-year 2022. However, taking into account the higher input costs that are affecting our supply chain operations, the constant currency-adjusted operating profit is down. The guidance for full-year dividend per share remains unchanged at 150 yen per share. The interim dividend is 75 yen per share.


Regarding Russia, despite continuing to manufacture and distribute our products in compliance with national and international sanctions, the operating environment is becoming increasingly complex. In this context, the JTI group continues to evaluate various options for its Russian business, including the possibility of transferring ownership, and will make necessary decisions in accordance with the group's management principles to address the constantly changing situation.


Please provide the text that needs to be translated.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Malaysia health minister says court conviction over vape promotion sets key precedent for Act 852 enforcement
Malaysia health minister says court conviction over vape promotion sets key precedent for Act 852 enforcement
Malaysia’s Health Minister Datuk Seri Dr Dzulkefly Ahmad said the Putrajaya Magistrate’s Court decision to convict a known personality for promoting vape has set an important legal precedent for enforcing the Control of Smoking Products for Public Health Act (Act 852).
Jan.09 by 2FIRSTS.ai
California DOJ publishes first-ever Unflavored Tobacco List; products not on the list are ineligible for sale
California DOJ publishes first-ever Unflavored Tobacco List; products not on the list are ineligible for sale
California Attorney General Rob Bonta announced the publication of the first-ever Unflavored Tobacco List (UTL), listing unflavored tobacco products lawful for sale under California’s flavored tobacco restrictions. Any covered tobacco product not appearing on the UTL is deemed a flavored tobacco product and ineligible for sale.
Jan.04 by 2FIRSTS.ai
IMiracle  Announces 2025 R&D Progress with Over 2,200 Patent Applications Worldwide
IMiracle Announces 2025 R&D Progress with Over 2,200 Patent Applications Worldwide
IMiracle announces significant R&D progress in 2025, with over 2,200 patent applications globally and 900 authorized patents.
Dec.18 by 2FIRSTS.ai
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.
Regulations
Dec.20 by 2Firsts Perspectives
Bangladesh enforces a complete ban on e-cigarettes and emerging tobacco products, with jail and heavy fines
Bangladesh enforces a complete ban on e-cigarettes and emerging tobacco products, with jail and heavy fines
UNB reports that Bangladesh has imposed a complete ban on e-cigarettes, vapes, and other emerging tobacco products as the Smoking and Tobacco Products Use Control (Amendment) Ordinance, 2025 has come into effect.
Jan.04 by 2FIRSTS.ai
The Volume Illusion: Measuring the Future of Nicotine with the Tools of the Past
The Volume Illusion: Measuring the Future of Nicotine with the Tools of the Past
As next-generation nicotine products become economically central rather than marginal, traditional volume-based metrics are increasingly unable to explain consumption, risk, and value. Units designed for a cigarette-based economy struggle to describe systems defined by delivery speed, pharmacokinetics, and adaptive user behavior. Drawing on financial reporting, regulation, and nicotine science, a fundamental question: can the future of nicotine still be measured using the tools of its past?
Feb.09 by Alan Zhao | 2Firsts Perspectives